Top

BMC Musculoskeletal Disorders

Published in:

Open Access 01-12-2021 | Antibiotic | Research article

Management of peri-prosthetic joint infection and severe bone loss after total hip arthroplasty using a long-stemmed cemented custom-made articulating spacer (CUMARS)

Authors: J. Quayle, A. Barakat, A. Klasan, A. Mittal, G. Chan, J. Gibbs, M. Edmondson, P. Stott

Published in: BMC Musculoskeletal Disorders | Issue 1/2021

Abstract

Background

There is little evidence on techniques for management of peri-prosthetic infection (PJI) in the context of severe proximal femoral bone loss. Custom-made articulating spacers (CUMARS) utilising cemented femoral stems as spacers was described providing better bone support and longer survival compared to conventional articulating spacers. We retrospectively report our experience managing PJI by adaptation of this technique using long cemented femoral stems where bone loss precludes use of standard stems.

Methods

Patients undergoing 1st stage revision for infected primary and revision THA using a cemented long stem (> 205 mm) and standard all-polyethylene acetabulum between 2011 and 2018 were identified. After excluding other causes of revision (fractures or aseptic loosening), Twenty-one patients remained out of total 721 revisions. Medical records were assessed for demographics, initial microbiological and operative treatment, complications, eradication of infection and subsequent operations. 2nd stage revision was undertaken in the presence of pain or subsidence.

Results

Twenty-one patients underwent 1st stage revision with a cemented long femoral stem. Mean follow up was 3.9 years (range 1.7–7.2). Infection was eradicated in 15 (71.4%) patients. Two patients (9.5%) required repeat 1st stage and subsequently cleared their infection. Three patients (14.3%) had chronic infection and are on long term suppressive antibiotics. One patient (4.8%) was lost to follow up before 2 years. Complications occurred in seven patients (33%) during or after 1st stage revision. Where infection was cleared, 2nd stage revision was undertaken in 12 patients (76.5%) at average of 9 months post 1st stage. Five (23.8%) CUMARS constructs remained in-situ at an average of 3.8 years post-op (range 2.6–5.1).

Conclusions

Our technique can be used in the most taxing of reconstructive scenarios allowing mobility, local antibiotic delivery, maintenance of leg length and preserves bone and soft tissue, factors not afforded by alternative spacer options.

Grammatopoulos G, Alvand A, Martin H, Whitwell D, Taylor A, Gibbons CLMH. Five-year outcome of proximal femoral endoprosthetic arthroplasty for non-tumour indications. Bone Joint J. 2016;98-B(11):1463–70. https://doi.org/10.1302/0301-620X.98B11.BJJ-2016-0244.R1.CrossRefPubMed

Kuiper JWP, Rustenburg CME, Willems JH, Verberne SJ, Peters EJG, Saouti R. Results and patient reported outcome measures (PROMs) after one-stage revision for Periprosthetic joint infection of the hip: a single-Centre retrospective study. J Bone Jt Infect. 2018;3(3):143–9. https://doi.org/10.7150/jbji.24366.CrossRefPubMedPubMedCentral

Rietbergen L, Kuiper JWP, Walgrave S, Hak L, Colen S. Quality of Life after Staged Revision for Infected Total Hip Arthroplasty: a systematic review. HIP International. 2016;26(4):311–8.CrossRef

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg. 2007;89(4):780–5.CrossRef

Patel A, Pavlou G, Mújica-Mota RE, Toms AD. The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J. 2015;97-B(8):1076–81. https://doi.org/10.1302/0301-620X.97B8.35170.CrossRefPubMed

Sakellariou VI. Management bone loss of the proximal femur in revision hip arthroplasty: update on reconstructive options. WJO. 2014;5(5):614–22. https://doi.org/10.5312/wjo.v5.i5.614.CrossRefPubMed

Grammatopoulos G, Kendrick B, McNally M, Athanasou NA, Atkins B, McLardy-Smith P, et al. Outcome Following Debridement, Antibiotics, and Implant Retention in Hip Periprosthetic Joint Infection-An 18-Year Experience. J Arthroplast. 2017;32(7):2248–55.CrossRef

George DA, Logoluso N, Castellini G, Gianola S, Scarponi S, Haddad FS, et al. Does cemented or cementless single-stage exchange arthroplasty of chronic periprosthetic hip infections provide similar infection rates to a two-stage? A systematic review. BMC Infect Dis. 2016;16(1):553. https://doi.org/10.1186/s12879-016-1869-4.CrossRefPubMedPubMedCentral

Gulhane S, Vanhegan IS, Haddad FS. Single stage revision: regaining momentum. J Bone Joint Surg (Br). 2012;94(11 Suppl A):120–2.CrossRef

10.

Ji B, Wahafu T, Li G, Zhang X, Wang Y, Momin M, et al. Single-stage treatment of chronically infected total hip arthroplasty with cementless reconstruction: results in 126 patients with broad inclusion criteria. Bone Joint J. 2019;101-B(4):396–402.CrossRef

11.

Leonard HAC, Liddle AD, Burke Ó, Murray DW, Pandit H. Single- or two-stage revision for infected Total hip Arthroplasty? A systematic review of the literature. Clin Orthop Relat Res. 2014;472(3):1036–42. https://doi.org/10.1007/s11999-013-3294-y.CrossRefPubMed

12.

Balato G, Ascione T, Rosa D, Pagliano P, Solarino G, Moretti B, et al. Release of gentamicin from cement spacers in two-stage procedures for hip and knee prosthetic infection: an in vivo pharmacokinetic study with clinical follow-up. J Biol Regul Homeost Agents. 2015;29(4 Suppl):63–72.PubMed

13.

Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement. J Arthroplast. 1998;13(3):331–8. https://doi.org/10.1016/S0883-5403(98)90179-6.CrossRef

14.

Chalmers BP, Mabry TM, Abdel MP, Berry DJ, Hanssen AD, Perry KI. Two-Stage Revision Total Hip Arthroplasty With a Specific Articulating Antibiotic Spacer Design: Reliable Periprosthetic Joint Infection Eradication and Functional Improvement. J Arthroplast. 2018;33(12):3746–53.CrossRef

15.

Biring GS, Kostamo T, Garbuz DS, Masri BA, Duncan CP. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. J Bone Joint Surg (Br). 2009;91(11):1431–7.CrossRef

16.

Jones CW, Selemon N, Nocon A, Bostrom M, Westrich G, Sculco PK. The influence of spacer design on the rate of complications in two-stage revision hip Arthroplasty. J Arthroplast. 2019;34(6):1201–6. https://doi.org/10.1016/j.arth.2019.02.012.CrossRef

17.

Hsieh PH, Shih CH, Chang YH, Lee MS, Yang WE, Shih HN. Treatment of deep infection of the hip associated with massive bone loss: two-stage revision with an antibiotic-loaded interim cement prosthesis followed by reconstruction with allograft. J Bone Joint Surg (Br). 2005;87(6):770–5.CrossRef

18.

Ben-Lulu O, Farno A, Gross AE, Backstein DJ, Kosashvili Y, Safir OA. A modified cement spacer technique for infected total hip arthroplasties with significant bone loss. J Arthroplast. 2012;27(4):613–9. https://doi.org/10.1016/j.arth.2011.06.031.CrossRef

19.

Tsang SJ, Ting J, Simpson AHRW, Gaston P. Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: a review of cohort studies. Bone Joint J. 2017;99-B(11):1458–66. https://doi.org/10.1302/0301-620X.99B11.BJJ-2017-0088.R1.CrossRefPubMed

20.

Tsung JD, Rohrsheim JA, Whitehouse SL, Wilson MJ, Howell JR. Management of periprosthetic joint infection after total hip arthroplasty using a custom made articulating spacer (CUMARS); the Exeter experience. J Arthroplast. 2014;29(9):1813–8. https://doi.org/10.1016/j.arth.2014.04.013.CrossRef

21.

Richards C, Bell CJ, Viswanathan S, English H, Crawford RW. Use of a cement-loaded Kuntscher nail in first-stage revision hip arthroplasty for massive femoral bone loss secondary to infection: a report of four cases. J Orthop Surg (Hong Kong). 2010;18(1):107–9. https://doi.org/10.1177/230949901001800124.CrossRef

22.

Mayes W, Edwards PK, Mears SC. Management of Severe Proximal Femur Bone Loss with a modular articulating antibiotic spacer. Geriatr Orthop Surg Rehabil. 2019;10:2151459319847399.CrossRef

23.

Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br Vol. 2008;90-B(12):1580–4. https://doi.org/10.1302/0301-620X.90B12.20742.CrossRef

24.

Alvand A, Grammatopoulos G, de Vos F, Scarborough M, Kendrick B, Price A, et al. Clinical Outcome of Massive Endoprostheses Used for Managing Periprosthetic Joint Infections of the Hip and Knee. J Arthroplast. 2018;33(3):829–34.CrossRef

25.

Quayle J, Barakat A, Klasan A, Mittal A, Stott P. External validation study of hip peri-prosthetic joint infection with cemented custom-made articulating spacer (CUMARS). Hip Int. 2020;28:1120700020960669.

26.

Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg (Br). 2012;94(5):619–23.CrossRef

27.

Kapadia BH, Banerjee S, Cherian JJ, Bozic KJ, Mont MA. The Economic Impact of Periprosthetic Infections After Total Hip Arthroplasty at a Specialized Tertiary-Care Center. J Arthroplast. 2016;31(7):1422–6.CrossRef

28.

Cooper HJ, Della Valle CJ. The two-stage standard in revision total hip replacement. Bone Joint J. 2013;95-B(11 Suppl A):84–7.

Title: Management of peri-prosthetic joint infection and severe bone loss after total hip arthroplasty using a long-stemmed cemented custom-made articulating spacer (CUMARS)
Authors: J. Quayle
A. Barakat
A. Klasan
A. Mittal
G. Chan
J. Gibbs
M. Edmondson
P. Stott
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Antibiotic
Joint Infection
Hip-TEP
Hip-TEP
Published in: BMC Musculoskeletal Disorders / Issue 1/2021
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/s12891-021-04237-1

At a glance: The STEP trials

Springer Medicine

Management of peri-prosthetic joint infection and severe bone loss after total hip arthroplasty using a long-stemmed cemented custom-made articulating spacer (CUMARS)

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

The first magnetically controlled growing rod (MCGR) in the world – lessons learned and how the identified complications helped to develop the implant in the past decade: case report

P2Y2 promotes fibroblasts activation and skeletal muscle fibrosis through AKT, ERK, and PKC

Effects of eccentric exercises on improving ankle dorsiflexion in soccer players

Repair of Lafosse I subscapularis injury adds no additional value in anterosuperior rotator cuff injury

Culture-negative chronic hematogenous osteomyelitis in a two months old girl: a case report

Myostatin and markers of bone metabolism in dermatomyositis